par Buisseret, Laurence
;Bareche, Yacine
;Venet, David
;Girard, Edwina;Gombos, Andrea
;Emonts, Patrick
;Majjaj, Samira
;Rouas, Ghizlane
;Serra, Matteo
;Debien, Véronique
;Agostinetto, Elisa;Garaud, Soizic
;Willard-Gallo, Karen
;Larsimont, Denis
;Stagg, John;Rothé, Françoise
;Sotiriou, Christos 
Référence ESMO Open, 9, 5, page (102964)
Publication Publié, 2024-05-01














Référence ESMO Open, 9, 5, page (102964)
Publication Publié, 2024-05-01
Article révisé par les pairs
Titre: |
|
Auteur: | Buisseret, Laurence; Bareche, Yacine; Venet, David; Girard, Edwina; Gombos, Andrea; Emonts, Patrick; Majjaj, Samira; Rouas, Ghizlane; Serra, Matteo; Debien, Véronique; Agostinetto, Elisa; Garaud, Soizic; Willard-Gallo, Karen; Larsimont, Denis; Stagg, John; Rothé, Françoise; Sotiriou, Christos |
Informations sur la publication: | ESMO Open, 9, 5, page (102964) |
Statut de publication: | Publié, 2024-05-01 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Humans |
Triple Negative Breast Neoplasms -- drug therapy -- immunology | |
Antibodies, Monoclonal, Humanized -- therapeutic use -- pharmacology | |
Retrospective Studies | |
Female | |
Biomarkers, Tumor -- metabolism | |
Middle Aged | |
Immunotherapy -- methods | |
Antineoplastic Agents, Immunological -- therapeutic use -- pharmacology | |
Aged | |
Adult | |
Lymphocytes, Tumor-Infiltrating -- immunology | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:2059-7029 |
info:doi/10.1016/j.esmoop.2024.102964 | |
info:pii/S2059702924007324 | |
info:scp/85192082647 | |
info:pmid/38703428 | |
PMC11087916 |